The novel substance is a low-molecular-weight peptide complex known as Coherin.
Coherin is not an antibiotic, not a steroid, and it's not a corticotropin-releasing hormone, contrary to what several people have claimed," said Dr.
Coherin was developed by a pair of Columbia University physicians who published a 19-patient pilot study in 1977.
35 mL of Coherin subcutaneously twice daily for 6 months and were followed out to 24 months.
After 1 month on Coherin, 16% of the patients were in clinical remission, as were 32% after 6 months.